EBE-A22
CAS No. 229476-53-3
EBE-A22( EBE-A22 | EBE A22 | EBEA22 )
Catalog No. M17448 CAS No. 229476-53-3
EBE-A22 is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | In Stock |
|
| 5MG | 76 | In Stock |
|
| 10MG | 106 | In Stock |
|
| 25MG | 215 | In Stock |
|
| 50MG | 327 | In Stock |
|
| 100MG | 492 | In Stock |
|
| 500MG | 1053 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEBE-A22
-
NoteResearch use only, not for human use.
-
Brief DescriptionEBE-A22 is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive.
-
DescriptionEBE-A22 is a derivative of PD 153035. EBE-A22, has no effect on EGF-R TK but maintains a high cytotoxic profile. EBE-A22 binds to DNA and behave as typical intercalating agents. EBE-A22 unwinds supercoiled plasmid, stabilizes duplex DNA against heat denaturation, and produces negative CD and ELD signals, as expected for an intercalating agent. EBE-A22, but not PD153035, interacts preferentially with GC-rich sequences and discriminates against homooligomeric runs of A and T which are often cut more readily by the enzyme in the presence of the drug compared to the control.
-
In Vitro——
-
In Vivo——
-
SynonymsEBE-A22 | EBE A22 | EBEA22
-
PathwayAngiogenesis
-
TargetFGFR
-
RecptorEGFR/ErbB1
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number229476-53-3
-
Formula Weight374.23
-
Molecular FormulaC17H16BrN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 133.61 mM; H2O : < 0.1 mg/mL
-
SMILESCN(c1cc(ccc1)Br)c1ncnc2cc(c(cc12)OC)OC
-
Chemical NameN-(3-bromophenyl)-6,7-dimethoxy-N-methylquinazolin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Goossens JF, et al. DNA interaction of the tyrosine protein kinase inhibitor PD153035 and its N-methyl analogue. Biochemistry. 2001 Apr 17;40(15):4663-71.
molnova catalog
related products
-
Aprutumab
Aprutumab (BAY 1179470) is a human FGFR2 monoclonal antibody with affinity to FGFR2 isoforms FGFR2-IIIB and FGFR2-IIIC. Aprutumab is commonly used to synthesize antibody-drug conjugates.
-
H3B-6527
A potent, highly selective covalent FGFR4 inhibitor with IC50 of <1.2 nM.
-
FGF-401
FGF-401 (NVP-FGF401, Roblitinib, FGF401)?is a first-in-class, potent, highly selective FGFR4 inhibitor with IC50 of 1.1 nM.
Cart
sales@molnova.com